QGEN
QIAGEN NV
NYSE · Healthcare · Medical - Diagnostics & Research · NL
$43.33
−2.37%Forward multiples
Based on analyst estimates
- P/E forward
- 17.36x
- P/E 2026E
- 18.16x
- P/E 2027E
- 16.87x
- P/E 2028E
- 15.42x
- P/S forward
- 4.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- 22.22x
- PEG TTM
- 0.81x
- Price / book
- 2.66x
- Price / sales
- 4.26x
- Price / cash flow
- 13.67x
Enterprise value
- Enterprise value
- $9.8B
- EV / sales
- 4.66x
- EV / EBITDA
- 13.31x
- EV / EBIT
- 18.41x
- Market cap
- $8.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026